Biscayne Pharmaceuticals Merges With Insero Health, Adding Clinical-Stage Novel Epilepsy Program And Other CNS Assets
--Insero Scientific Co-founder and Harvard Epilepsy Expert Dr. Steven Schachter Joins Biscayne as Senior Science Advisor----Drug Development Veteran Stephen Collins Is Named CEO and Launches Series...
Bristol-Myers Squibb and Moffitt Cancer Center Enter Into a Collaboration Agreement as Part of U.S. Immuno-Oncology Rare Population Malignancy Program
September 25, 2015 NEW YORK & TAMPA, Fla.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Moffitt Cancer Center today announced that they have entered into a collaboration...
Florida Institute Funds Orlando-based Aviana Molecular Technologies
Gainesville and Boca Raton, FL., Sept. 24, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement...
Florida Institute Funds Medical Technology Company MYOLYN
Gainesville and Boca Raton, FL, Sept. 15, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement...
Florida Institute Funds Pensacola-based Robotics Unlimited Inc.
Core Technology Licensed from the Florida Institute for Human and Machine Cognition (IHMC) GAINESVILLE and BOCA RATON, FL., Sept. 10, 2015 -- The Florida Institute for the Commercialization of...